コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 most common mutation is in the gene encoding complement factor H.
2 02 protein polymorphism in the gene encoding complement factor H.
3 ed, i.e., TSG-6, chemokines IL-8 and KC, and complement factor H.
4 The purified protein was identified as human complement factor H.
5 and OPN form rapid and tight complexes with complement Factor H.
6 the complement cascade C1q, C6, and C8; and complement factor H.
7 ble proteins, such as C-reactive protein and complement factor H.
15 g two host-derived fluid-phase regulators of complement, factor H and factor H-like protein 1 (FHL-1)
16 d with genetic complement abnormalities/anti-complement factor H antibodies, which paved the way to t
17 convalescent B1b cell-derived IgM recognizes complement factor H-binding protein (FhbA), a B. hermsii
19 ants were genotyped for polymorphisms in the complement factor H (CFH) and age-related maculopathy su
21 the relationship between local (ie, ocular) complement factor H (CFH) and choroidal neovascularizati
23 tion cluster at chromosome 1q32 contains the complement factor H (CFH) and five complement factor H-r
24 s study, we investigated the associations of complement factor H (CFH) and hemicentin-1 (HMCN1) with
25 ctivation and genetic variants in inhibitory complement factor H (CFH) are also features of both ARMD
26 In addition, to determine the regulation of complement factor H (CFH) by oxidative stress, in vitro
28 f this disease, identifying mutations in the complement factor H (CFH) gene and a locus on chromosome
30 anding puzzle why non-coding variants in the complement factor H (CFH) gene are more strongly associa
32 S, with a focus on genetic variations in the complement Factor H (CFH) gene cluster and CFH autoantib
33 us carriers of the Y402H risk variant in the complement factor H (CFH) gene developed neovascular AMD
34 ransition at amino acid position 402) in the complement factor H (CFH) gene have a pharmacogenetics e
35 ty variants and protective haplotypes in the complement factor H (CFH) gene modulate risk for AMD.
36 mparted by carrying the Y402H variant in the complement factor H (CFH) gene on chromosome 1, recent e
37 on of a rare, high-penetrance variant in the complement factor H (CFH) gene that is also causally ass
40 A locus on chromosome 1q31.1 containing the complement factor H (CFH) gene was strongly associated w
42 ted maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH) genotypes, and other factors,
44 gh interaction with an SNP (rs380390) in the complement factor H (CFH) intron reported to be highly a
54 Y402H and I62V substitutions in the gene for complement factor H (CFH) is strongly associated with ri
56 eptor 1 (CR1) on human erythrocytes (Es) and complement factor H (CFH) on rodent platelets perform im
57 This activation is efficiently suppressed by complement factor H (CFH) on self-surfaces but not on fo
58 smoking, and presence of risk alleles of the complement factor H (CFH) or age-related maculopathy sus
59 plicated in the disease pathology, including complement factor H (CFH) precursor and alpha-2-macroglo
61 erage of 10.1 years, individuals with 1 or 2 complement factor H (CFH) risk alleles derived maximum b
62 hyperopia, and AMD-susceptibility genotypes Complement Factor H (CFH) RS1061170 and Age Related Macu
64 have associated a common variant (Y402H) of complement factor H (CFH) with a highly significant incr
67 t form of HUS maps to chromosome 1q and that complement factor H (CFH), a regulatory component of the
69 mplementary to the 3'-untranslated region of complement factor H (CFH), an important repressor of the
70 y complement fluid-phase regulatory protein, complement factor H (CFH), are strongly associated with
72 ilies were filtered for rare variants in the complement factor H (CFH), complement factor I (CFI), co
73 Genetic variation across the genes encoding complement factor H (CFH), factor B (CFB) and component
75 sm, encoding the sequence variation Y402H in complement factor H (CFH), has been strongly associated
77 Two common variants in the gene encoding complement factor H (CFH), the Y402H substitution (rs106
78 that binds the negative complement regulator complement factor H (CFH), thereby inhibiting the altern
79 ponses by hijacking a host-immune regulator, complement factor H (CFH), to the bacterial surface.
80 ly it to a comparison of hemopexin (HPX) and complement factor H (CFH), two liver-secreted glycoprote
83 th age, sex, smoking status, presence of the complement factor H (CFH)-rs1061170 and age-related macu
88 her [age-related macular degeneration (AMD); complement factor H (CFH)], or even three disease charac
89 Genetic risk factors such as variations in complement factors H (CFH) and B (CFB) have been implica
97 plement control protein (CCP) modules within complement factor H (fH) encompass binding sites for C3b
98 iC3b, and C3dg and enhanced competition with complement factor H (FH) in surface plasmon resonance (S
104 soluble plasma-regulatory proteins including complement factor H (fH), a 155 kDa protein composed of
105 ement-mediated innate immunity by recruiting complement factor H (FH), a complement alternative pathw
110 MD (P = .03); between rs2669845 and Y402H in complement factor H for AMD (P = .04); and between rs266
112 typed, an intronic and common variant in the complement factor H gene (CFH) is strongly associated wi
113 actors--smoking and the Y402H variant of the complement factor H gene (CFH)--we used logistic regress
115 tion studies have found variation within the complement factor H gene family links to host susceptibi
117 kely caused by the Y402H polymorphism in the complement factor H gene is a recognized risk factor for
118 T-->C substitution in exon 9 (Y402H) of the complement factor H gene is strongly associated with sus
119 age, sex, and the Y402H polymorphism in the complement factor H gene on chromosome 1q) and mortality
124 work presented here demonstrates that human complement factor H is an adhesion ligand for human neut
125 und in locus 1q31.3, containing the gene for complement factor H (lead single nucleotide polymorphism
126 n up to 50% of cases, caused by mutations in complement factor H, membrane cofactor protein, factor I
128 fluid-phase CRP to six immobilized proteins: complement factor H, oxidized low-density lipoprotein, c
129 serine peptidase 1) (P =2.7 x 10(-72)), CFH (complement factor H) (P =2.3 x 10(-47)), C2 (complement
132 is revealed a novel heterozygous mutation in complement factor H (R83S) in addition to known risk pol
133 tients carrying a genetic abnormality in the complement factor H related 1 gene (CFHR1) that originat
137 The autoimmune renal disease deficient for complement factor H-related (CFHR) genes and autoantibod
141 C3G-associated genomic mutation in the gene complement factor H-related 1 (CFHR1), which encodes FHR
142 onstrates that a duplication within the gene complement factor H-related 1 (CFHR1; encoding FHR1) lea
143 ociation studies have shown that deletion of complement factor H-related genes 1 and 3 (CFHR3,1Delta)
144 e association studies identified deletion of complement factor H-related genes 1 and 3 as protective
146 ing the association of rs7517126 with plasma complement factor H-related protein 1 (CFHR1) level at p
147 , Factor H, Factor H-like protein-1 (FHL-1), complement Factor H-related protein 1 (CFHR1), and plasm
148 and endogenous nitric oxide production) and complement factor H-related protein 2 (CFHR2, related to
149 e cosegregated with the same mutation in the complement factor H-related protein 5 gene (CFHR5).
151 riants suggest decreased inhibition of C3 by complement factor H, resulting in increased activation o
155 noncoding variant in CFH, the gene encoding complement factor H, that substantially increases the in
156 with these diseases affect the glycoprotein complement factor H, the main regulator of the alternati
157 first to a cell surface receptor and then to complement Factor H thereby blocking the lytic activity
158 are disrupted by the abundant serum protein, complement Factor H, thereby probably limiting SIBLING-m
159 characteristic of sub-RPE deposits, such as complement factor H, vitronectin, and amyloid beta, reve
160 a-2-glycoprotein and positively with afamin, complement factor H, VLDL-associated apolipoproteins, an
162 venger receptors, IgM natural antibodies and complement factor H, which bind, neutralize and/or facil
163 association of ARM with the Y402H allele of complement factor H, which has previously been reported
164 e mutant also had decreased binding of human complement Factor H, which in previous studies increased
165 Maculopathy Susceptibility 2 rs10490924 and Complement Factor H Y402H (P for trend = 4.2x10(-7)).
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。